Published inRedbud VCWhy We Invested in SynvectSynvect is a biotech company focused on developing innovative genetic solutions for mosquito population control.Dec 26, 2024Dec 26, 2024
Published inRedbud VCRedbud VC 2024 Year-in-ReviewRedbud VC 2024 Year-in-ReviewDec 23, 2024Dec 23, 2024
Published inRedbud VCThoughts on Generalist vs. Specialist InvestingGeneralist investors can adapt to changes in the market and develop diverse pattern recognition, which influences power law success.Nov 18, 2024Nov 18, 2024
Published inRedbud VCBruno Ostarcevic, New Redbud VC Venture PartnerWe are delighted to welcome Bruno Ostarcevic as Redbud VC’s newest venture partner.Aug 13, 2024Aug 13, 2024
Introducing The VC ListThe VC List: Data on 18k venture capital funds and angel investors, including over 7k emailsAug 8, 2024A response icon3Aug 8, 2024A response icon3
Published inRedbud VCKate Hanick, New Redbud VC MBA AssociateMeet Kate Hanick, the newest edition to the Redbud VC team. Kate joins us as Redbud VC’s first MBA Associate.Aug 5, 2024Aug 5, 2024
Published inRedbud VCWhy We Invested In FairFair is an embedded auto warranty platform, boosting revenue for industry companies and providing transparent warranties.Jul 30, 2024A response icon1Jul 30, 2024A response icon1
Published inRedbud VCWhy We Invested In Biography HealthBiography Health is a preventative health platform for physicians to analyze and track a patient’s genomic-based health story.Jul 15, 2024A response icon1Jul 15, 2024A response icon1
Published inRedbud VCWhy We Invested In ReactivReactiv is an automated mobile app development platform for brands and developers.Jun 6, 2024Jun 6, 2024
Published inRedbud VCWhy We Invested In BraidBraid is an API platform that enables financial institutions to launch or plug into fintechs for new revenue opportunitiesMay 1, 2024May 1, 2024
